Fructus Ligustrum lucidi inhibits inflammatory mediator release through inhibition of nuclear factor-κB in mouse peritoneal macrophages

Author:

An Hyo-Jin1,Jeong Hyun-Ja1,Um Jae-Young1,Kim Hyung-Min1,Park Yun-Jum2,Park Rae-Kil3,Kim Eun-Cheol4,Na Ho-Jeong5,Shin Tae-Yong5,An Hyo-Jin6,Hong Seung-Heon6

Affiliation:

1. College of Oriental Medicine, Institute of Oriental Medicine, Oriental Medical Science Center, Kyung Hee University, 1-Hoegi-Dong, Dongdaemun-Gu, Seoul 130–701, Republic of Korea

2. Division of Horticulture and Pet Animal-Plant Science, Wonkwang University, Shinyong-dong, Iksan, Republic of Korea

3. VestibuloCochlear Research Center of Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570–749, Republic of Korea

4. Department of Oral & Maxillofacial Pathology, College of Dentistry, Wonkwang University, Iksan, South Korea

5. College of Pharmacy, Woosuk University, Jeonbuk, Republic of Korea

6. College of Pharmacy and VCRC of Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570–749, Republic of Korea

Abstract

Abstract Fructus Ligustrum lucidi (FLL) is a widely used herbal medicine for the treatment of a variety of pathologies. We have investigated the anti-inflammatory mechanism of FLL in mouse peritoneal macrophages. FLL exerted an anti-inflammatory action through inhibition of lipopolysaccharide (LPS)-induced tumour necrosis factor (TNF)-α production in mouse peritoneal macrophages. The maximal inhibition rate of TNF-α production by FLL (0.5 mg mL−1) was 60.88 + 0.30%. In the inflammatory process, nitric oxide (NO) and prostaglandin E2 (PGE2) increased in peritoneal macrophages. FLL decreased the protein level of NO and PGE2 in LPS-stimulated mouse peritoneal macrophages. In addition, FLL inhibited nuclear factor-κB activation and IκB-α degradation by the decrease in IκB-α phosphorylation. Our study suggested that FLL reduced inflammation via an important molecular mechanism, which might explain its beneficial effect in the regulation of inflammatory reactions.

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3